| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 36, 1408-1427, Copyright © 1990 by American Association for Clinical Chemistry
JP Gosling
Department of Biochemistry, University College, Galway, Ireland.
Immunoassays are now very widely used in the clinical laboratory, either because no other type of assay system is feasible or because they are often the most effective and suitable of the possible analytical methods. The last decade has seen the development and refinement of many new immunoassay reagents and systems. The major trend has been away from liquid-phase assays involving radioisotopic labels, towards fast homogeneous or solid-phase assays capable of operation anywhere; and towards precise and reliable nonisotopic, automated or semi-automated laboratory assays, often with detection limits measured in pico- or attomoles. The use of monoclonal antibodies is now widespread, and the methodologies of labels and of solid-phase components are much more sophisticated. New assay formulations, novel homogeneous systems, immunosensors, free-analyte assays, the importance of thorough validation and of interfering substances, and future trends are discussed.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  E. Ozan, F. Ayhan, and H. Ayhan Anti C-Reactive Protein Immobilization Onto Poly(glycidyl Methacrylate) Microspheres and its Use for Diagnosis Journal of Bioactive and Compatible Polymers, January 1, 2008; 23(1): 69 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 J. R. Lakowicz, J. Malicka, E. Matveeva, I. Gryczynski, and Z. Gryczynski Plasmonic Technology: Novel Approach to Ultrasensitive Immunoassays Clin. Chem., October 1, 2005; 51(10): 1914 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Taieb, B. Mathian, F. Millot, M.-C. Patricot, E. Mathieu, N. Queyrel, I. Lacroix, C. Somma-Delpero, and P. Boudou Testosterone Measured by 10 Immunoassays and by Isotope-Dilution Gas Chromatography-Mass Spectrometry in Sera from 116 Men, Women, and Children Clin. Chem., August 1, 2003; 49(8): 1381 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schweitzer, S. Wiltshire, J. Lambert, S. O'Malley, K. Kukanskis, Z. Zhu, S. F. Kingsmore, P. M. Lizardi, and D. C. Ward Immunoassays with rolling circle DNA amplification: A versatile platform for ultrasensitive antigen detection PNAS, August 17, 2000; (2000) 170237197. [Abstract] [Full Text]
|
|
|
|
|
|
C. P. Price The Evolution of Immunoassay as Seen Through the Journal Clinical Chemistry Clin. Chem., October 1, 1998; 44(10): 2071 - 2074. [Full Text] [PDF]
|
|
|
|
|
|
P. Luppa, C. Bruckner, I. Schwab, S. Hauck, S. Schmidmayr, C. Birkmayer, B. Paulus, and H. Hauptmann 7{alpha}-Biotinylated testosterone derivatives as tracers for a competitive chemiluminescence immunoassay of testosterone in serum Clin. Chem., December 1, 1997; 43(12): 2345 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Van Lente Methodology and Subspecialty Consolidation in the Clinical Laboratory Clin. Chem., January 1, 1997; 43(1): 11 - 12. [Full Text] [PDF]
|
|
|
|
|
|
B. Schweitzer, S. Wiltshire, J. Lambert, S. O'Malley, K. Kukanskis, Z. Zhu, S. F. Kingsmore, P. M. Lizardi, and D. C. Ward Inaugural Article: Immunoassays with rolling circle DNA amplification: A versatile platform for ultrasensitive antigen detection PNAS, August 29, 2000; 97(18): 10113 - 10119. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
